Novoheart Holdings Inc. Opens the Market
October 12 2017 - 10:46AM
PR Newswire (Canada)
TORONTO, Oct. 12, 2017 /CNW/ - Professor Ronald Li, CEO & Scientific Co-Founder,
Novoheart Holdings Inc., joined Rob
Peterman, Vice-President, Global Business Development, TMX
Group, to open the market. Novoheart is a global stem cell
biotechnology company dedicated to human heart engineering with
offices in Vancouver, British
Columbia, the United States
and Hong Kong. Novoheart Holdings
Inc. commenced trading on TSX Venture Exchange on October 3, 2017.
SOURCE TMX Group Limited
Copyright 2017 Canada NewsWire
Novoheart (TSXV:NVH)
Historical Stock Chart
From Nov 2024 to Dec 2024
Novoheart (TSXV:NVH)
Historical Stock Chart
From Dec 2023 to Dec 2024
